Wikidata

(Q43991568)

English

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

scientific article

In more languages

Statements

title
Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017
author name string
Ch Dittrich
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017
M Borner
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017
K Weigang-Köhler
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017
H Huisman
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017
A Amelsberg
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017
J Wanders
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017
A Hanauske
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017
P Fumoleau
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017
page(s)
1072-1080
1 reference
stated in
Europe PubMed Central
PubMed ID
12008195
retrieved
28 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43991568&oldid=2143381352"